89
Views
1
CrossRef citations to date
0
Altmetric
Review

Ocular Neuromyotonia: an update

ORCID Icon, &
Pages 217-223 | Received 09 Oct 2020, Accepted 23 Feb 2021, Published online: 07 Mar 2021

References

  • Roper-Hall G, Chung SM, Cruz OA. Ocular neuromyotonia: differential diagnosis and treatment. Strabismus. 2013;21(2):131–136.
  • Soares-Dos-Reis R, Martins AI, Brás A, et al. Ocular neuromyotonia. Pract Neurol. 2018Oct 1;18(5):389–390.
  • Stockman AC, Dieltiëns M, Janssens H, et al. Ocular neuromyotonia: case reports and literature review. Strabismus. 2018;26(3):133–141.
  • Chung SM, Lee AG, Holds JB, et al. Ocular neuromyotonia in graves dysthyroid orbitopathy. Arch Ophthalmol. 1997;115(3):365–370.
  • Eggenberger ER. Ocular neuromyotonia: report of 2 cases, review of the literature and pathophysiologic hypothesis. Neuro-Ophthalmology. 1999;21(4):249–254.
  • Shults WT, Hoyt WF, Behrens M, et al. Ocular neuromyotonia: a clinical description of six patients. Arch Ophthalmol. 1986;104(7):1028–1034.
  • Johns RJ, Knox DL, Walsh FB, et al. Involuntary eye movements in a patient with myasthenia and hyperthyroidism. Arch Ophthalmol. 1962;67(1):35–41.
  • Clark E. A case of apparent intermittent overaction of the left superior oblique. Br Orthopt J. [ cited]. 1966 [2020Aug23];23:116–117.
  • Ricker K, Mertens HG. Ocular neuromyotony. Klin Monbl Augenheilkd. 1970;156(6):837–842.
  • Küçükali CI, Kürtüncü M, Akçay HI, et al. Peripheral nerve hyperexcitability syndromes. Rev Neurosci. 2015;26(2):239–251.
  • Lang B, Makuch M, Moloney T, et al. Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. J Neurol Neurosurg Psychiatry. 2017;88(4):353–361.
  • Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734–2748.
  • Giardina AS, Slagle WS, Greene AM, et al. Novel case of ocular neuromyotonia associated with thyroid-related orbitopathy and literature review. Optom Vis Sci. 2012;89(12):12.
  • Fricke J, Neugebauer A, Rüßmann W. Ocular neuromyotonia : a case report. Strabismus. 2002;10(2):119–124.
  • Kamermans M, Fahrenfort I. Ephaptic interactions within a chemical synapse: Hemichannel-mediated ephaptic inhibition in the retina. Curr Opin Neurobiol. 2004;14(5):531–541.
  • Maïna I, Tabi CB, Ekobena Fouda HP, et al. Discrete impulses in ephaptically coupled nerve fibers. Chaos. 2015;25(4):4.
  • Hartline DK. What is myelin? Neuron Glia Biol. 2008;4(2):153–163.
  • Smith KJ, McDonald WI. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc B Biol Sci. 1999;354(1390):1649–1673.
  • Love S, Coakham HB. Trigeminal neuralgia: Pathology and pathogenesis. Brain. 2001;124(12):2347–2360.
  • Kameyama S, Masuda H, Shirozu H, et al. Ephaptic transmission is the origin of the abnormal muscle response seen in hemifacial spasm. Clin Neurophysiol. 2016;127(5):2240–2245.
  • Sano K, Morii K, Sato M, et al. Radiation-induced diffuse brain injury in the neonatal rat model. Neurol Med Chir (Tokyo). Vol. 40. 2000. p. 495–500.
  • Sze WCC, McQuillan J, Plowman PN, et al. Stereotactic radiosurgery XX: ocular neuromyotonia in association with gamma knife radiosurgery. Endocrinol Diabetes Metab Case Rep. 2015 [2015(Aug)]. 10.1530/EDM-14-0106
  • Haupert CL, Newman NJ. Ocular neuromyotonia 18 years after radiation therapy. Arch Ophthalmol. 1997;115(10):1331–1332.
  • Kim A, Velez F, Pineles S. Strabismus Surgery in Patients with ocular neuromyotonia: Potential unmasking of the condition and effective management tool. J Neuro Ophthalmol. 2016;36(3):259–263.
  • Tilikete C, Vial C, Niederlaender M, et al. Idiopathic ocular neuromyotonia: a neurovascular compression sydrome? J Neurol Neurosurg Psychiatry. 2000;69(5):642–644.
  • Padungkiatsagul T, Jindahra P, Poonyathalang A, et al. Bilateral oculomotor ocular neuromyotonia: a case report. BMC Neurol. 2018;18(1):1–4. .
  • Vanikieti K, Rizzo JF. Teaching video neuro images: bilateral abducens ocular neuromyotonia. Neurology. 2017;89(10):e128.
  • Ali ZC, Usmani HA, Ansons A. A rare case of bilateral ocular neuromyotonia. Can J Ophthalmol. 2018;53(1):e4–6.
  • Abdulla N, Eustace P. A case of ocular neuromyotonia with tonic pupil. J Neuro Ophthalmol. 1999;19(2):125–127.
  • Ezra E, Spalton D, Sanders MD, et al. Ocular neuromyotonia. Br J Ophthalmol. 1996;80(4):350–355.
  • Frohman EM, Zee DS. Ocular neuromyotonia: clinical features, physiological mechanisms, and response to therapy. Ann Neurol. 1995;37(5):620–626.
  • Choi K, Hwang J, Park S, et al. Primary aberrant regeneration and neuromyotonia of the third cranial nerve. J Neuro Ophthalmol. 2006;26(4):248–250.
  • Kau HC, Tsai CC. Abducens ocular neuromyotonia in a patient with nasopharyngeal carcinoma following concurrent chemoradiotherapy. J Neuro-Ophthalmol. 2010;30(3):266–267.
  • Daubert J, Hariharan L, Pasol J, et al. Ocular neuromyotonia noted after recent botulinum toxin injection for sixth nerve palsy following resection of a posterior fossa skull base meningioma. Neuro-Ophthalmology. 2015;39(1):39–41.
  • Yee R, Purvin V. Ocular neuromyotonia: three case reports with eye movement recordings. J Neuro Ophthalmol. 1998;18(1):1–8.
  • Boschi A, Spiritus M, Cioffi M, et al. Ocular neuromyotonia in a case of Paget’s disease of bone. Neuro-Ophthalmology. 1997;18(2):67–71.
  • Banks MC, Caruso PA, Midbrain-Thalamic Ocular LS. Neuromyotonia. Arch Ophthalmol. 2005;123(1):118–119.
  • Harrison AR, Wirtschafter JD. Ocular neuromyotonia in a patient with cavernous sinus thrombosis secondary to mucormycosis. Am J Ophthalmol. 1997;124(1):122–123.
  • Kung NH, Bucelli RC, McClelland CM, et al. Ocular neuromyotonia associated with chronic inflammatory demyelinating polyneuropathy. Neuro-Ophthalmology. 2015;39(5):240–242.
  • Menon D, Sreedharan SE, Gupta M, et al. A novel association of ocular neuromyotonia with brainstem demyelination: Two case reports. Mult Scler. 2014;20(10):1409–1412.
  • Tandon A, Oliveira C. Superior oblique myokymia, a review. Curr Opin Ophthalmol. 2019;30(6):472–475.
  • Salman MS, Klassen SF, Clark IH. Congenital oculomotor nerve paresis with isolated cyclic pupillary spasms. J Neuro-Ophthalmol. 2015;35(4):371–373.
  • Nan H, Jing Y. Oculomotor paresis with cyclic spasms: Description of four cases and hypothesis of the mechanism. J Psychiatry Psychiatr Disord. 2019;03(4):191–199.
  • Loewenfeld I, Thompson SH. Oculomotor paresis with cyclic spasms. A critical review of the literature and a new case. Surv Ophthalmol. 1975;20:2.
  • Miller NR, Lee AG. Adult-onset acquired oculomotor nerve paresis with cyclic spasms: relationship to ocular neuromyotonia. Am J Ophthalmol. 2004;137(1):70–76.
  • Much JW, Weber ED, Newman SA. Ocular neuromyotonia after gamma knife stereotactic radiation therapy. J Neuroophthalmol. 2009;29(2):136–139.
  • FDA. Tegretol: Carbamazepine [Internet]. 2009 [ cited 2020Sep7]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/016608s101,018281s048lbl.pdf
  • Nicoletti P, Barrett S, McEvoy L, et al. Shared genetic risk factors across carbamazepine-induced hypersensitivity reactions. Clin Pharmacol Ther. 2019;106(5):1028–1036.
  • Plant GT. Putting ocular neuromyotonia in context. J Neuro Ophthalmol. 2006;26(4):241–243.
  • Oohira A, Furuya T. Ocular neuromyotonia with spastic lid closure. J Neuro Ophthalmol. 2006;26(4):244–247.
  • Cruz FM, Blitz AM, Subramanian PS. Partial third nerve palsy and ocular neuromyotonia from displacement of posterior communicating artery detected by high-resolution MRI. J Neuro-Ophthalmol. 2013;33(3):263–265.
  • Gadoth A, Kipervasser S, Korczyn AD, et al. Acquired oculomotor nerve paresis with cyclic spasms in a young woman, a rare subtype of neuromyotonia. J Neuro-Ophthalmol. 2013;33(3):247–248.
  • Kim SB, Oh SY, Chang MH, et al. Oculomotor neuromyotonia with lid ptosis on abduction. J Aapos. 2013;17(1):97–99.
  • Strupp M, Dieterich M, Brandt T, et al. Therapy of vestibular paroxysmia, superior oblique myokymia, and ocular neuromyotonia. Curr Treat Options Neurol [Internet]. 2016;18(7):1-16.
  • FDA. Gabapentin (NEURONTIN) [Internet]. 2017 [ cited 2021Jan9]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf
  • FDA. Dilantin (Phenytoin sodium) [Internet]. 2009 [ cited 2021Jan9]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/084349s060lbl.pdf
  • De Saint Sardos A, Vincent A, Aroichane M, et al. Ocular neuromyotonia in a 15-year-old girl after radiation therapy. J Aapos. 2008;12(6):616–617.
  • FDA. Lacosamide [Internet]. 2008 [ cited 2021Jan9]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204994Orig1s000lbl.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.